3rd Quarter - Report
TODD STRATEGY GROUP for ALKERMES, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Prescription drug pricing. Substance Use Disorder Policy. Awareness of outcomes data and the need for training on all medication assisted treatment. Implementation of Inflation Reduction Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | — |
| JEFF LUCAS | — |
| DANIEL M TODD | — |
| NICHOLAS UEHLECKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.